1 October 2012, Berlin, Germany. Immediately before EASD. Save the date!
Read moreNews Alert
The EU invests €30 million to map
new territory in health research
Brussels, 3 October 2011
BBC Radio 4 report on BLUEPRINT (4 minutes)
Q&A with BLUEPRINT’s Henk Stunnenberg on Epiexperts.com, social media site
The EU has invested €30 million to understand the epigenome - a link between genes, environment and health. BLUEPRINT, a new large-scale research project, will lead to targeted diagnostics, new treatments and preventive measures for specific diseases in individual patients; an approach known as 'personalised medicine'. BLUEPRINT, officially launched on 1 October, is the European cornerstone of an international research cooperation effort – the International Human Epigenome Consortium (IHEC), bringing together organisations and researchers from across the globe. The project upholds the EU's pledge to maximise open access to results of publicly-funded research, as teams from around the world will have a platform to openly share their results.
Read more: http://ec.europa.eu/research/index.cfm?pg=newsalert&lg=en&year=2011&na=na-031011
1 October 2012, Berlin, Germany. Immediately before EASD. Save the date!
Read moreOn Wednesday 14 March 2012, the European Parliament adopted a Resolution on Addressing the EU Diabetes Epidemic
Read moreHealth priorities of the Danish Presidency place focus on chronic diseases with diabetes as a model disease
Read moreWebsite for Horizon 2020 now open, the Framework Programme for Research and Innovation at the European Commission
Read moreAddress: Meiersfelder Str. 33 32760 Detmold Germany
Tel/Fax: 0049-5231-56 999 63